Home  >  Products  >  AGER (advanced glycosylation end product-specific receptor) Blocking Peptide (the N terminal of protein) (100ug)
AGER (advanced glycosylation end product-specific receptor) Blocking Peptide (the N terminal of protein) (100ug)

AGER (advanced glycosylation end product-specific receptor) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-AGER antibody (Catalogue #: ARP41464_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP41464
Size: 100 ug
Weight: 34kDa
Gene: 177
Format: Lyophilized powder
Target: AGER mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. It is receptor for amyloid beta peptide.
Alternative names: MGC22357; RAGE
See Full Product Listings >